The cryptic immunopeptidome in health and disease.

Autor: Kina E; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada., Larouche JD; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada., Thibault P; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada., Perreault C; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada. Electronic address: claude.perreault@umontreal.ca.

Publikováno v: Trends in genetics : TIG [Trends Genet] 2024 Oct 09. Date of Electronic Publication: 2024 Oct 09.

Breast cancer immunopeptidomes contain numerous shared tumor antigens.

Autor: Kina E; Institute for Research in Immunology and Cancer (IRIC), and.; Department of Medicine, University of Montreal, Montreal, Quebec, Canada., Laverdure JP; Institute for Research in Immunology and Cancer (IRIC), and., Durette C; Institute for Research in Immunology and Cancer (IRIC), and., Lanoix J; Institute for Research in Immunology and Cancer (IRIC), and., Courcelles M; Institute for Research in Immunology and Cancer (IRIC), and., Zhao Q; Institute for Research in Immunology and Cancer (IRIC), and.; Department of Medicine, University of Montreal, Montreal, Quebec, Canada., Apavaloaei A; Institute for Research in Immunology and Cancer (IRIC), and.; Department of Medicine, University of Montreal, Montreal, Quebec, Canada., Larouche JD; Institute for Research in Immunology and Cancer (IRIC), and.; Department of Medicine, University of Montreal, Montreal, Quebec, Canada., Hardy MP; Institute for Research in Immunology and Cancer (IRIC), and., Vincent K; Institute for Research in Immunology and Cancer (IRIC), and., Gendron P; Institute for Research in Immunology and Cancer (IRIC), and., Hesnard L; Institute for Research in Immunology and Cancer (IRIC), and., Thériault C; Institute for Research in Immunology and Cancer (IRIC), and., Ruiz Cuevas MV; Institute for Research in Immunology and Cancer (IRIC), and.; Department of Medicine, University of Montreal, Montreal, Quebec, Canada., Ehx G; Laboratory of Hematology, GIGA-I3, University of Liege and CHU of Liège, Liege, Belgium., Thibault P; Institute for Research in Immunology and Cancer (IRIC), and.; Department of Chemistry, University of Montreal, Montreal, Quebec, Canada., Perreault C; Institute for Research in Immunology and Cancer (IRIC), and.; Department of Medicine, University of Montreal, Montreal, Quebec, Canada.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Jan 02; Vol. 134 (1). Date of Electronic Publication: 2024 Jan 02.

BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens.

Autor: Cuevas MVR; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC, H3C 3J7, Canada., Hardy MP; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada., Larouche JD; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada.; Department of Medicine, Université de Montréal, Montreal, QC, H3C 3J7, Canada., Apavaloaei A; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada.; Department of Medicine, Université de Montréal, Montreal, QC, H3C 3J7, Canada., Kina E; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada.; Department of Medicine, Université de Montréal, Montreal, QC, H3C 3J7, Canada., Vincent K; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada., Gendron P; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada., Laverdure JP; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada., Durette C; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada., Thibault P; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada.; Department of Chemistry, Université de Montréal, Montreal, QC, H3C 3J7, Canada., Lemieux S; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC, H3C 3J7, Canada., Perreault C; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada.; Department of Medicine, Université de Montréal, Montreal, QC, H3C 3J7, Canada., Ehx G; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, H3C 3J7, Canada. g.ehx@uliege.be.; Laboratory of Hematology, GIGA-I3, University of Liege, CHU of Liege, Liege, Belgium. g.ehx@uliege.be.

Publikováno v: Genome biology [Genome Biol] 2023 Aug 15; Vol. 24 (1), pp. 188. Date of Electronic Publication: 2023 Aug 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.